PER 2.22% 9.2¢ percheron therapeutics limited

Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-64

  1. 31 Posts.
    lightbulb Created with Sketch. 36
    I personally have no idea why some give Akki such a hard time just because his/her views are contrary to your own. In fact Akki has been correct about a number of things over the years and has never beat his/her chest over it. I use Akki's comments as a way to challenge my own thoughts on the company.

    I still remember Akki correctly pointed out during Serepta's CR that their comments regarding partnerships and acquisitions was a generic paragraph they always include in all their previous CRs but received backlash over it. Unpopular opinion but Akki is one of the few posters I actually pay attention to. At least he/she doesn't flood their comments with $ $ $ $ symbols and post outrageous share price predictions.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.2¢
Change
0.002(2.22%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.9¢ 9.2¢ 8.8¢ $69.71K 769.3K

Buyers (Bids)

No. Vol. Price($)
2 35742 9.0¢
 

Sellers (Offers)

Price($) Vol. No.
9.2¢ 84100 2
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
9.2¢
  Change
0.002 ( 3.37 %)
Open High Low Volume
8.9¢ 9.2¢ 8.8¢ 138646
Last updated 15.59pm 14/06/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.